US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium) – PR Newswire (press release)
US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium) PR Newswire (press release) … administration of some other lipid-lowering therapies (fibrates or niacin ), gemfibrozil, cyclosporine, lopinavir/ritonavir, or atazanavir/ritonavir. …
Go here to see the original:
US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium) – PR Newswire (press release)
- Tags: approves, fda, indication, lipid, newswire, Niacin, press-release